Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ARK Genomic Revolution ETF (NY:ARKG)

38.64 -1.23 (-3.09%)
Streaming Delayed Price Updated: 10:21 AM EDT, Jul 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 854,192
Open 39.58
Bid (Size) 38.64 (300)
Ask (Size) 38.65 (100)
Prev. Close 39.87
Today's Range 38.63 - 39.66
52wk Range 22.73 - 44.47
Shares Outstanding 418,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cathie Wood Just Bet Big on This Biotech Stock ↗
Ionis Pharmaceuticals' shares are down more than 27% so far this year. What does Cathie Wood see that others are missing? 
Via The Motley Fool
Topics ETFs
News headline image
Cathie Wood's Ark Invest Sold $7.4 Million of BioNTech Stock ↗
Cathie Wood's biotech ETF has largely moved on from the vaccine maker. 
Via The Motley Fool
Topics ETFs

Performance

YTD
+32.4%
+32.4%
1 Month
+6.2%
+6.2%
3 Month
+23.7%
+23.7%
6 Month
+22.2%
+22.2%
1 Year
+53.8%
+53.8%

More News

Read More
News headline image
Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy? ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs
BEAM Stock In Focus As FDA Alignment Wins William Blair’s Praise ↗
Via Stocktwits
News headline image
Why Is CRSP Stock Falling Pre-Market Today? ↗
Via Stocktwits
News headline image
RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial ↗
Via Stocktwits
News headline image
CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗
Via Stocktwits
News headline image
TWST Shares Rise 8% — What’s Driving The Rally? ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗
Via Stocktwits
Topics Artificial Intelligence ETFs
News headline image
Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗
Via The Motley Fool
Topics ETFs
News headline image
Why Tempus AI Stock Soared This Week ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗
Via Benzinga
Topics ETFs
News headline image
Wellgistics Health's 200% Surge Puts AI-Pharma Tie-Ups On The ETF Map ↗
Via Benzinga
Topics Artificial Intelligence ETFs
News headline image
Wellgistics And DataVault Team Up To Transform Prescription Tracking ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet ↗
Via Benzinga
Topics ETFs Government
News headline image
Nancy Pelosi, Cathie Wood Align On These 4 Stocks – Do You Own Any? ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Nancy Pelosi's Tempus Play Might Be Smartest Trade In Washington — Stock Surges 200% ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
Via Benzinga
Topics ETFs
News headline image
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI ↗
Via Benzinga
News headline image
Cathie Wood, Dan Ives Align On These 11 AI Stock Picks — Some Might Surprise You ↗
Via Benzinga
Topics Artificial Intelligence ETFs
News headline image
Cathie Wood's Ark Pivots: Sells Tempus AI After FDA Win, Loads Up On Amazon, Figma And This Trendy Crypto Stock ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood's Ark Dumps $2.1 Million Of This Hot AI Stock Despite Recent Acquisition Boost ↗
Via Benzinga
Topics Artificial Intelligence ETFs
News headline image
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers ↗
Via Benzinga
Topics ETFs
News headline image
Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade ↗
Via Benzinga
Topics ETFs

Frequently Asked Questions

Is ARK Genomic Revolution ETF publicly traded?
Yes, ARK Genomic Revolution ETF is publicly traded.
What exchange does ARK Genomic Revolution ETF trade on?
ARK Genomic Revolution ETF trades on the New York Stock Exchange
What is the ticker symbol for ARK Genomic Revolution ETF?
The ticker symbol for ARK Genomic Revolution ETF is ARKG on the New York Stock Exchange
What is the current price of ARK Genomic Revolution ETF?
The current price of ARK Genomic Revolution ETF is 38.64
When was ARK Genomic Revolution ETF last traded?
The last trade of ARK Genomic Revolution ETF was at 07/20/26 10:21 AM ET
What is the market capitalization of ARK Genomic Revolution ETF?
The market capitalization of ARK Genomic Revolution ETF is 16.15M
How many shares of ARK Genomic Revolution ETF are outstanding?
ARK Genomic Revolution ETF has 16M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.